Lactobacillus probiotics have been successfully used in vitro in imiquimoid-induced psoriasis in mice, resulting in lower gene expression levels of pro-inflammatory markers such as TNF-α, IL-19, IL-17A, and IL-23, as well as lower PASI scores [89,90]. The gene discussed is IL17A; the disease is psoriasis.